Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S (NY: NVO )

72.68 USD -0.15 (-0.21%)
Streaming Delayed Price Updated: 4:00 PM EST, Mar 2, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 449,673
Open 72.84
Bid (Size) 72.68 (1)
Ask (Size) 73.92 (1)
Prev. Close 72.83
Today's Range 72.39 - 73.00
52wk Range 49.24 - 75.86
Shares Outstanding 2,419,274,059
Dividend Yield 1.25%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Novo Nordisk A/S (NYSE:NVO) Notice: Investigation for Investors in Formerly Emisphere Technologies, Inc. (OTC:EMIS) over Takeover
San Diego, CA -- (SBWIRE) -- 02/24/2021 -- An investigation was announced concerning whether the takeover of Emisphere Technologies, Inc. is unfair to OTC:EMIS stockholders. 
From SBWire - Latest Press Releases
Diabetes drug hailed as a breakthrough for weight loss
A study by researchers at the University of Leeds revealed a drug used to treat diabetes can lead to significant weight loss in obese individuals. 
Tags TWTR NVO
From MarketWatch

Performance

YTD
+1.75%
+1.75%
1 Month
+3.22%
+3.22%
3 Month
+8.27%
+8.27%
6 Month
+10.05%
+10.05%
1 Year
+18.91%
+18.91%

More News

Read More
Novo Nordisk: Q4 Earnings Insights
Tags NVO Market News Benzinga
From Benzinga
Novo Nordisk Shares Gain On Fourth Quarter Earnings Beat, Stock Repurchase Program
Tags Health Care News Guidance
From Benzinga
Novo Nordisk A/S (NVO) Q4 2020 Earnings Call Transcript
Tags Market News NVO
From Motley Fool
Lots Of News Day
Tags Stocks / Equities
From Blogs - TalkMarkets
European stocks and U.S. futures rise as earnings lift big corporates
Tags UK:GLEN IT:UCG IT:ISP
From MarketWatch
7 Safe Stocks to Buy for Solid Returns in Tumultuous Times
Tags NVO ED WMMVY
From InvestorPlace
‘Manufacturers and middlemen have created a vicious cycle of price increases’: Mark Cuban pledges to sell this $225 medication for $20
Tags NVO CVS LLY
From MarketWatch
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
Tags NGM HZNP AYTU
From Benzinga
A Batch Of News
Tags Stocks / Equities Market News
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.